Katrin Kleinmanns

6PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 14, 2026
Establishment of a humanized patient-derived xenograft mouse model of high-grade serous ovarian cancer for preclinical evaluation of combination immunotherapy.

Luka Tandaric, Line Bjørge, Martine Rott Lode

|Oct 28, 2023
Combining Mass Cytometry Data by CyTOFmerge Reveals Additional Cell Phenotypes in the Heterogeneous Ovarian Cancer Tumor Microenvironment: A Pilot Study.

Liv Cecilie Vestrheim Thomsen, Katrin Kleinmanns, Shamundeeswari Anandan

|Jul 09, 2022
Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies.

Katrin Kleinmanns, Stein-Erik Gullaksen, Geir Bredholt

|Jun 24, 2022
Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes.

Maria Grazia Perrone, Paola Vitale, Morena Miciaccia

|Mar 06, 2021
Phenotypic Characterization by Mass Cytometry of the Microenvironment in Ovarian Cancer and Impact of Tumor Dissociation Methods.

Shamundeeswari Anandan, Liv Cecilie V Thomsen, Stein-Erik Gullaksen

|Dec 02, 2020
The Emerging Role of CD24 in Cancer Theranostics-A Novel Target for Fluorescence Image-Guided Surgery in Ovarian Cancer and Beyond.

Katrin Kleinmanns, Vibeke Fosse, Line Bjørge

Pageof 1

Frequent Collaborators

5 joint publications

Line Bjørge

3 joint publications

Stein-Erik Gullaksen

2 joint publications

Emmet McCormack

1 joint publications

Bjørn Tore Gjertsen